CSAM Health Group (CSAM-ME)

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2023.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 13 April 2023 until 21 April 2023 CSAM has purchased a total of 6,960 own shares at an average price of 41.1559 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
13.04.2023 00:00:00 1,031 39.7000 40,930.70
14.04.2023 00:00:00 285 43.0000 12,255.00
17.04.2023 00:00:00 1,232 40.1000 49,403.20
18.04.2023 00:00:00 1,246 41.4878 51,693.80
19.04.2023 00:00:00 1,175 41.6548 48,944.40
20.04.2023 00:00:00 808 41.5000 33,532.00
21.04.2023 00:00:00 1,183 42.0000 49,686.00

Previously disclosed buy-backs under the programme (aggregate) 55,989 37.1538 2,080,206.42
Total purchased under the programme 62,949 37.5963 2,366,651.52

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

CSAM Health Group AS: Minutes from the annual general meeting

The annual general meeting of CSAM Health Group AS was held today, 27 April 2023, at the Company’s headquarters in Oslo.

All proposals in the agenda were adopted.
…

Vis børsmeldingen

The minutes from the annual general meeting are attached with this notification.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 24 April 2023 until 3 May 2023 CSAM has purchased a total of 7,868 own shares at an average price of 40.1643 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
24.04.2023 00:00:00 1,645 40.9030 67,285.44
25.04.2023 00:00:00 1,881 40.3894 75,972.46
26.04.2023 00:00:00 1,873 40.6944 76,220.61
27.04.2023 00:00:00 0 n.a. n.a.
28.04.2023 00:00:00 937 37.8834 35,496.75
02.05.2023 00:00:00 1,231 40.0232 49,268.56
03.05.2023 00:00:00 301 39.1000 11,769.10

Previously disclosed buy-backs under the programme (aggregate) 62,949 37.5963 2,366,651.52
Total purchased under the programme 70,817 37.8816 2,682,664.43

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached with this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Invitation to presentation of CSAM Health Group’s Q1 results

CSAM Health Group AS (CSAM) will publish its results for the first quarter of 2023 on Friday, 12 May at 08:00 CEST(UTC+2) on newsweb.oslobors.no and www.csamhealth.com/investor-relations.

A presentation of the results, including a discussion of recent events, will be given by CEO Sverre Flatby and CFO Einar Bonnevie at 08:30 CEST(UTC+2) via webcast, which can be accessed at www.csamhealth.com/live.
…

Vis børsmeldingen

The webcast will be held in English and will include a live Q&A session.

A recording and a transcript of the webcast will be made available following the event.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn.
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Presentation of CSAM Health Group’s results for the first quarter of 2023

Today, CSAM Health Group AS (CSAM) presented its financial results for the first quarter of 2023 during a shareholder webcast. CEO Sverre Flatby and CFO Einar Bonnevie presented highlights from the report and a detailed overview of the financial results for the quarter.

The full webcast can be viewed at www.csamhealth.com/investor-relations/reports-and-webcasts/
…

Vis børsmeldingen

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 4 May 2023 until 12 May 2023 CSAM has purchased a total of 4,879 own shares at an average price of 43.1525 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
04.05.2023 00:00:00 0 n.a. n.a.
05.05.2023 00:00:00 121 40.8000 4,936.80
08.05.2023 00:00:00 0 n.a. n.a.
09.05.2023 00:00:00 1,655 42.0000 69,510.00
10.05.2023 00:00:00 1,677 42.9865 72,088.36
11.05.2023 00:00:00 953 42.8951 40,879.03
12.05.2023 00:00:00 473 48.8941 23,126.91

Previously disclosed buy-backs under the programme (aggregate) 70,817 37.8816 2,682,664.43
Total purchased under the programme 75,696 38.2214 2,893,205.53

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached with this report.

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 15 May 2023 until 25 May 2023 CSAM has purchased a total of 7,509 own shares at an average price of 47.6815 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
15.05.2023 00:00:00 1,427 48.0000 68,496.00
16.05.2023 00:00:00 821 48.4467 39,774.74
19.05.2023 00:00:00 0 n.a. n.a.
22.05.2023 00:00:00 1,242 46.2432 57,434.05
23.05.2023 00:00:00 1,405 47.8214 67,189.07
24.05.2023 00:00:00 1,725 46.4293 80,090.50
25.05.2023 00:00:00 889 50.6817 45,056.03

Previously disclosed buy-backs under the programme (aggregate) 75,696 38.2214 2,893,205.53
Total purchased under the programme 83,205 39.0751 3,251,245.93

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 26 May 2023 until 6 June 2023 CSAM has purchased a total of 3,521 own shares at an average price of 45.0921 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
26.05.2023 00:00:00 426 47.7235 20,330.21
30.05.2023 00:00:00 706 47.9000 33,817.40
31.05.2023 00:00:00 0 n.a. n.a.
01.06.2023 00:00:00 1,238 45.2868 56,065.06
02.06.2023 00:00:00 0 n.a. n.a.
05.06.2023 00:00:00 1,151 42.1865 48,556.66
06.06.2023 00:00:00 0 n.a. n.a.

Previously disclosed buy-backs under the programme (aggregate) 83,205 39.0751 3,251,245.93
Total purchased under the programme 86,726 39.3194 3,410,015.26

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 7 June 2023 until 15 June 2023 CSAM has purchased a total of 1,762 own shares at an average price of 42.8264 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
07.06.2023 00:00:00 162 41.1000 6,658.20
08.06.2023 00:00:00 131 40.3588 5,287.00
09.06.2023 00:00:00 0 n.a. n.a.
12.06.2023 00:00:00 0 n.a. n.a.
13.06.2023 00:00:00 1,374 43.3224 59,524.98
14.06.2023 00:00:00 95 42.0000 3,990.00
15.06.2023 00:00:00 0 n.a. n.a.

Previously disclosed buy-backs under the programme (aggregate) 86,726 39.3194 3,410,015.26
Total purchased under the programme 88,488 39.3892 3,485,475.44

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 16 June 2023 until 26 June 2023 CSAM has purchased a total of 2,665 own shares at an average price of 44.9571 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
16.06.2023 00:00:00 744 45.2289 33,650.30
19.06.2023 00:00:00 0 n.a. n.a.
20.06.2023 00:00:00 1,350 42.9809 58,024.22
21.06.2023 00:00:00 0 n.a. n.a.
22.06.2023 00:00:00 571 49.2751 28,136.08
23.06.2023 00:00:00 0 n.a. n.a.
26.06.2023 00:00:00 0 n.a. n.a.

Previously disclosed buy-backs under the programme (aggregate) 88,488 39.3892 3,485,475.44
Total purchased under the programme 91,153 39.5520 3,605,286.04

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 27 June 2023 until 05 July 2023 CSAM has purchased a total of 9,835 own shares at an average price of 42.7584 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
27.06.2023 00:00:00 993 43.4758 43,171.50
28.06.2023 00:00:00 583 45.5592 26,561.00
29.06.2023 00:00:00 1,066 43.3917 46,255.60
30.06.2023 00:00:00 2,253 45.0194 101,428.80
03.07.2023 00:00:00 2,457 41.1224 101,037.80
04.07.2023 00:00:00 2,483 41.1091 102,073.80
05.07.2023 00:00:00 0 n.a. n.a.
Previously disclosed buy-backs under the programme (aggregate) 91,153 39.5520 3,605,286.04
Total purchased under the programme 100,988 39.8643 4,025,814.54

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 06 July 2023 until 14 July 2023 CSAM has purchased a total of 7,984 own shares at an average price of 42.8661 per share.

Aggregated overview of transactions per day:
Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
06/07/2023 00:00:00 279 40.8971 11,410.30
07/07/2023 00:00:00 258 40.3000 10,397.40
10/07/2023 00:00:00 2,628 40.0000 105,120.00
11/07/2023 00:00:00 0 n.a. n.a.
12/07/2023 00:00:00 2,540 45.2881 115,031.70
13/07/2023 00:00:00 275 41.7000 11,467.50
14/07/2023 00:00:00 2,004 44.3193 88,815.80

Previously disclosed buy-backs under the programme (aggregate) 100,988 39.8643 4,025,814.54
Total purchased under the programme 108,972 40.0842 4,368,057.24

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 15 July 2023 until 25 July 2023 CSAM has purchased a total of 12,708 own shares at an average price of 42.8278 per share.

Aggregated overview of transactions per day:
Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
17/07/2023 00:00:00 1,740 43.5083 75,704.50
18/07/2023 00:00:00 2,078 42.6664 88,660.80
19/07/2023 00:00:00 697 41.8000 29,134.60
20/07/2023 00:00:00 0 n.a. n.a.
21/07/2023 00:00:00 1,953 41.4250 80,903.10
24/07/2023 00:00:00 2,690 43.8627 117,990.60
25/07/2023 00:00:00 3,550 42.7779 151,861.50
Previously disclosed buy-backs under the programme (aggregate) 108,972 40.0842 4,368,057.24
Total purchased under the programme 121,680 40.3707 4,912,312.34

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 26 July 2023 until 03 August 2023 CSAM has purchased a total of 11,081 own shares at an average price of 41.7320 per share.

Aggregated overview of transactions per day:
Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
26/07/2023 00:00:00 701 41.7621 29,275.23
27/07/2023 00:00:00 1,819 40.4068 73,499.97
28/07/2023 00:00:00 1,909 43.4252 82,898.71
31/07/2023 00:00:00 0 n.a. n.a.
01/08/2023 00:00:00 1,470 42.7380 62,824.86
02/08/2023 00:00:00 2,176 42.1806 91,784.99
03/08/2023 00:00:00 3,006 40.6350 122,148.81
Previously disclosed buy-backs under the programme (aggregate) 121,680 40.3707 4,912,312.34
Total purchased under the programme 132,761 40.4844 5,374,744.90

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 04 August 2023 until 14 August 2023 CSAM has purchased a total of 22,474 own shares at an average price of 39.1993 per share.

Aggregated overview of transactions per day:
Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
04/08/2023 00:00:00 0 n.a. n.a.
07/08/2023 00:00:00 2,954 38.9046 114,924.19
08/08/2023 00:00:00 4,470 36.9800 165,300.60
09/08/2023 00:00:00 5,423 38.0008 206,078.34
10/08/2023 00:00:00 2,573 38.8879 100,058.57
11/08/2023 00:00:00 3,659 42.0875 153,998.16
14/08/2023 00:00:00 3,395 41.4152 140,604.60

Previously disclosed buy-backs under the programme (aggregate) 132,761 40.4844 5,374,744.90
Total purchased under the programme 155,235 40.2983 6,255,709.36

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Invitation to presentation of CSAM Health Group’s Q2 results

CSAM Health Group AS (CSAM) will publish its results for the second quarter of 2023 on Friday, 25 August at 08:00 CEST (UTC +2) on newsweb.oslobors.no and www.csamhealth.com/investor-relations.

A presentation of the results, including a discussion of recent events, will be given by CEO Sverre Flatby and CFO Einar Bonnevie at 08:30 CEST (UTC +2) via webcast, which can be accessed at www.csamhealth.com/live.
…

Vis børsmeldingen

The webcast will be held in English and will include a live Q&A session.

A recording and transcript of the webcast will be made available following the event.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn.
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.
…

Vis børsmeldingen

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

From 15 August 2023 until 23 August 2023 CSAM has purchased a total of 27,830 own shares at an average price of 41.9479 per share.

Aggregated overview of transactions per day:
Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
15/08/2023 00:00:00 1,215 44.0627 53,536.20
16/08/2023 00:00:00 4,078 41.0158 167,262.60
17/08/2023 00:00:00 6,854 41.3580 283,467.50
18/08/2023 00:00:00 6,692 42.4383 283,997.30
21/08/2023 00:00:00 0 n.a. n.a.
22/08/2023 00:00:00 3,545 40.8174 144,697.60
23/08/2023 00:00:00 5,446 43.0498 234,449.10
Previously disclosed buy-backs under the programme (aggregate) 155,235 40.2983 6,255,709.36
Total purchased under the programme 183,065 40.5491 7,423,119.66

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

CSAM Health Group announces 16% growth for the second quarter of 2023

Oslo, Norway, 25 August 2023: Today, CSAM Health Group AS (CSAM), a leading provider of specialised software for healthcare, published its results for the second quarter of 2023.

CSAM Health Group continues to grow and reported revenues of NOK 104 million for Q2-23, a 16% increase over Q2-22. Recurring revenue saw a similar growth rate and reached NOK 82 million in Q2-23, up from 70 million for the same period last year.
…

Vis børsmeldingen

CSAM CEO Sverre Flatby highlights the healthy and steady growth: “The revenue year-to-date reached NOK 206.3 million, and we are on track to reach our target of passing the NOK 400 million mark for the year. We are proud to be on the trajectory to reach that revenue milestone, while also seeing our EBITDA margin continuing its positive development. After the implementation of the cost reduction programme earlier this year, we saw EBITDA margins turn positive to 5% in Q1-23, and last quarter it reached 10%.”

CSAM’s growth in recurring revenue originates from a solid fundament of long-term contracts in several countries. It also covers all of CSAM’s business areas, making it a diversified revenue stream with minor customer churn.

“We are optimistic that our cost reduction programme will continue to yield results, and we expect EBITDA margins for our existing businesses to steadily increase towards the 30% target. In addition, our ambition to grow through M&A remains central to our strategy, and we are continuously in dialogue with interesting parties,” concludes Flatby.

Highlights from the report:
• Q2-23 total income 104 MNOK vs 90 MNOK in Q2-22
• Recurring revenue grew 16% to 82 MNOK (Q2-23 vs Q2-22), and accounted for 79% of total sales
• Reported EBITDA was 11 MNOK resulting in a 10% EBITDA margin
• Q2-23 organic growth of 10.6% vs Q2-22 in local currency (15.1% in NOK)
• Gross margin increased to 91% (90%)

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

CSAM Health Group AS - Notice of Extraordinary General Meeting

The Board of Directors of CSAM Health Group AS hereby convenes an Extraordinary General Meeting at the Company’s offices in Drammensveien 288, 0283 Oslo, on 26 September 2023 at 10 CEST (UTC +2).

The purpose of the meeting is to decide on the proposed change of name of CSAM Health Group AS and to elect a new board member.
…

Vis børsmeldingen

The Board encourages all shareholders to use the opportunity to submit a power of attorney before the meeting, as described in the attached Notice.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde

[TekBot]

Presentation of CSAM Health Group’s results for the second quarter of 2023

Today, CSAM Health Group AS (CSAM) presented its financial results for the second quarter of 2023 during a shareholder webcast. CEO Sverre Flatby and CFO Einar Bonnevie presented highlights from the report and a detailed overview of the financial results for the quarter.

The full webcast can be viewed at www.csamhealth.com/investor-relations/reports-and-webcasts/
…

Vis børsmeldingen

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH

Kilde